British watchdog rejects GSK’s lupus drug again

by ctotheb

British watchdog rejects GSK’s lupus drug again

Britain’s healthcare cost watchdog has rejected GlaxoSmithKline’s lupus drug Benlysta a second time after the company offered an undisclosed discount, saying it still failed to offer good value for money.

Advertisements